Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 600 clinical trials
Camrelizumab /Apatinib for Recurrent Platinum-resistant Ovarian Cancer

This study is intend to improve the progression-free survial of the recurrent paltinum-resistant ovarian cancer. All the participants will receive camrelizumab combined with apatinib.

  • 0 views
  • 23 Mar, 2021
  • 1 location
Phase 3 Trial Evaluating Hyperthermic Intraperitoneal Chemotherapy in Upfront Treatment of Stage IIIC Epithelial Ovarian Cancer

unresectable epithelial tubal/ovarian cancer with partial or complete response after 3 cycles of 1st line chemotherapy (CBDCA +Paclitaxel).

ovarian epithelial cancer
cancer chemotherapy
carboplatin
cytoreductive surgery
paclitaxel
  • 67 views
  • 08 Nov, 2020
  • 2 locations
Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer (EOC): A Phase III Randomized Study

To determine the impact of Neoadjuvant chemotherapy on surgical debulking rate, overall and disease-free survival and quality of life (QOL) in patients with advanced EOC.

ovarian epithelial cancer
cancer
carcinoma
ovarian cancer
ovarian carcinoma
  • 19 views
  • 07 Nov, 2020
  • 1 location
A Phase I/II Study of Paclitaxel Plus Carboplatin Plus Vorinostat in Recurrent Ovarian Cancer

TITLE:A Phase II non-comparative study of paclitaxel plus carboplatin in combination with Vorinostat in patients with advanced, recurrent epithelial ovarian cancer. INDICATION:Second-line

ovarian epithelial cancer
fallopian tube
carboplatin
paclitaxel
recurrent ovarian cancer
  • 10 views
  • 07 Nov, 2020
  • 1 location
Trial of Active Immunotherapy With Globo H-KLH (OPT-822/821) in Women Who Have Non-Progressive Ovarian Cancer

The purpose of this study is to evaluate the effect of OPT-822/OPT-821 on improving Progression-Free Survival (PFS) in subjects who have non-progressive epithelial ovarian, fallopian tube, or primary peritoneal cancer after cytoreductive surgery and platinum-based chemotherapy as initial treatment for primary disease or as salvage treatment for first relapse.

peritoneal cancer
platinum-based chemotherapy
fallopian tube
cytoreductive surgery
primary peritoneal carcinoma
  • 36 views
  • 07 Nov, 2020
  • 1 location
Adjuvant Whole Abdominal Intensity Modulated Radiotherapy (IMRT) for High Risk Stage FIGO III Patients With Ovarian Cancer

The prognosis for patients with advanced epithelial ovarian cancer remains poor despite aggressive surgical resection and platinum-based chemotherapy. More than 60% of patients will

ovarian epithelial cancer
carboplatin
platinum-based chemotherapy
paclitaxel
residual tumor
  • 46 views
  • 07 Nov, 2020
  • 1 location
Gemcitabine Paclitaxel Ifosfamide and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors

RATIONALE: Drugs used in chemotherapy, such as gemcitabine, paclitaxel, ifosfamide, and cisplatin, work in different ways to stop tumor cells from dividing so they stop growing or die. Giving more than one drug (combination chemotherapy) may kill more tumor cells. PURPOSE: This phase I/II trial is studying the side effects …

filgrastim
germ cell tumor
tumor cells
paclitaxel
gemcitabine
  • 32 views
  • 07 Nov, 2020
  • 1 location
Neoadjuvant Chemotherapy With Carboplatin and Docetaxel in Patients With Advanced Ovarian Cancer-Prospective Randomized Phase II Clinical Trial

The purpose of this study is to evaluate response to neoadjuvant chemotherapy by imaging and observation of anatomical and biological indicators (i.e. ascites or continuous measurement of tumor marker CA 125). Furthermore the optimal number of preoperative administered cycles of combination chemotherapy with carboplatin and docetaxel should be determined.

tumor markers
docetaxel
carboplatin
combination chemotherapy
cancer antigen 125
  • 2 views
  • 07 Nov, 2020
  • 1 location
  • 0 views
  • 28 Jan, 2021
  • 1 location
  • 0 views
  • 12 Jun, 2021
  • 7 locations